WSJ
28 Jul 2026, 11:47 UTC · 4h ago
GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
WSJ
28 Jul 2026, 11:47 UTC · 4h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
The company is targeting annual savings of $2.52 billion by 2029. — Significant cost-cutting measures typically expand margins and improve bottom-line earnings per share.
+0.60CEO Luke Miels has outlined a roadmap to achieve the company's 2031 sales targets. — Clear strategic guidance on long-term growth provides visibility to investors and reduces uncertainty.
+0.30Which stocks this story touches
The company is implementing a significant cost-savings plan to reach its long-term sales targets.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
24/7 Wall Street
57m ago
